Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vaginal Lactobacillus Pretreatment for FET Outcomes in PCOS with Dysbiosis
ChiCTR2000036460Phase 3Recruiting
- Sponsor
- International Peace Maternity and Child Health Hospital
- Start
- Oct 2020
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Countries
- 1
01
Overview
Phase 3, randomised trial of live double combined lactobacillus in polycystic ovary syndrome (PCOS) (2 arms), sponsored by International Peace Maternity and Child Health Hospital. Primary endpoints: Pregnancy rate, Implantation rate and 1 more. Started Oct 2020; status: recruiting.
02
Drugs
live double combined lactobacillus
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on ChiCTR2000036460.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000036460.